Rincon Bio performs PC-3 xenograft models to test efficacy of preclinical therapies. Please see below for additional information or to request a quote.
Organism: Homo sapiens, human / Tissue: prostate; derived from metastatic site: bone / Disease: grade IV, adenocarcinoma
PC-3 cells were derived from 62 year old male Caucasian with grade IV adenocarcinoma
Used in xenografts to test the efficacy of novel cancer therapeutics. Tumors develop after being injected into the flank of immunocompromised mice.
WHY WORK WITH
When you work with Rincon Bio, rest assured that all cancer efficacy studies will be performed in the USA, at competitive prices
Most efficacy studies can be initiated within two business days.
We love our clients! We are flexible and easy to work with. And we take a personal interest in our clients' studies.